Studies

CellWell record HH-4553

Thermosensitive, injectable, biocompatible epigallocatechin gallate liposomes/modified chitosan composite hydrogel for efficient skin repairing.

Huang Z; Wen W; Huang S; Yu Y; Cao Y; Xiang H; Xu D; Xuan J; Zhang L; Peng W; Qin S

Journal of drug targeting ยท 2026

In plain language

A preclinical study on green tea catechins (EGCG) found that animal experiments demonstrate that ELSCN with a high concentration of EGCG can promote wound healing by reducing skin inflammation, boosting collagen synthesis, facilitating epidermal repair and promoting granulation tissue formation.

Evidence
Emerging
Design
Preclinical study

Read it on PubMed

Powered by CellWell

Cite this record: https://thecellwell.org/studies/HH-4553

Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.

This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.